BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 3592637)

  • 41. DNA content of nasopharyngeal carcinoma: an independent prognostic indicator.
    Hsu MM; Chiou CR; Ko JY; Sheen TS; Hong RL; Ting LL
    Cancer Detect Prev; 2000; 24(2):119-26. PubMed ID: 10917131
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cytospectrophotometric analysis of DNA content in the invasive cancer of the vervix.
    Maruszczak AJ; Olkowski ZL; Maruszczak D; McLaren JR
    Strahlentherapie; 1975 Mar; 149(3):310-7. PubMed ID: 1145664
    [TBL] [Abstract][Full Text] [Related]  

  • 43. No prognostic impact of flow-cytometric measured DNA ploidy and S-phase fraction in cancer of the uterine cervix: a prospective study of 465 patients.
    Kristensen GB; Kaern J; Abeler VM; Hagmar B; Tropé CG; Pettersen EO
    Gynecol Oncol; 1995 Apr; 57(1):79-85. PubMed ID: 7705705
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prognostic influence of ploidy level and histopathologic differentiation in cervical carcinoma stage Ib.
    Jakobsen A; Bichel P; Kristensen GB; Nyland M
    Eur J Cancer Clin Oncol; 1988 Jun; 24(6):969-72. PubMed ID: 3409946
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Prediction of radiosensitivity by DNA analysis].
    Kubota S; Sato S; Nakano T; Morita S; Tunemoto H; Ando K; Sekiya T; Sugishita T
    Gan No Rinsho; 1989 Oct; 35(13):1572-5. PubMed ID: 2585728
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tumor proliferation and apoptosis in human uterine cervix carcinoma I: correlations between variables.
    Tsang RW; Fyles AW; Li Y; Rajaraman MM; Chapman W; Pintilie M; Wong CS
    Radiother Oncol; 1999 Jan; 50(1):85-92. PubMed ID: 10225561
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Flow cytometric evaluation of DNA ploidy pattern and cell heterogeneity in cervical dysplasia and carcinoma in situ].
    Watanabe T
    Nihon Sanka Fujinka Gakkai Zasshi; 1993 Dec; 45(12):1381-8. PubMed ID: 8270821
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Flow cytometric DNA patterns in cervical carcinoma.
    Strang P; Stendahl U; Frankendal B; Lindgren A
    Acta Radiol Oncol; 1986; 25(4-6):249-54. PubMed ID: 3030052
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Flow cytometric analysis of DNA ploidy and S-phase fraction of Stage IIIB cervical carcinoma.
    Wilailak S; Rochanawutanon M; Srisupundit S; Aumkhyan A; Pattanapanyasat K
    Eur J Gynaecol Oncol; 2004; 25(4):428-30. PubMed ID: 15285296
    [TBL] [Abstract][Full Text] [Related]  

  • 50. DNA level and stereologic estimates of nuclear volume in squamous cell carcinomas of the uterine cervix. A comparative study with analysis of prognostic impact.
    Sørensen FB; Bichel P; Jakobsen A
    Cancer; 1992 Jan; 69(1):187-99. PubMed ID: 1727663
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [An analysis of nuclear DNA histogram of adenocarcinoma of the uterine cervix].
    Yoshida K
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Jun; 41(6):723-8. PubMed ID: 2768967
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of prognostic factors following flow-cytometric DNA analysis after cytokeratin labelling: II. Cervical and endometrial cancer.
    Wimberger P; Hillemanns P; Kapsner T; Hepp H; Kimmig R
    Anal Cell Pathol; 2002; 24(4-5):147-58. PubMed ID: 12590151
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Flow cytometric analysis of nasopharyngeal carcinoma].
    Chen XJ
    Zhonghua Zhong Liu Za Zhi; 1990 Mar; 12(2):82-4. PubMed ID: 2401181
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Retrospective DNA analysis by rapid high resolution cytometry in cases with cervical cancer before and after radiotherapy.
    Izutsu T; Kagabu T; Nishiya I; Wied GL
    Nihon Sanka Fujinka Gakkai Zasshi; 1988 Jul; 40(7):909-14. PubMed ID: 3418197
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The current status of flow cytometry in gynecologic oncology.
    Braly PS
    Oncology (Williston Park); 1992 Jan; 6(1):23-8, 31; discussion 31-3. PubMed ID: 1531602
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Flow cytometry (FCM) in the assay of DNA content of normal and malignant epithelial cells of human uterine cervix and the prognostic significance of DNA content: I. Methodology].
    Wu AR
    Zhonghua Zhong Liu Za Zhi; 1985 Mar; 7(2):87-90. PubMed ID: 2408835
    [No Abstract]   [Full Text] [Related]  

  • 57. Prognostic significance of vascular density and a malignancy grading in radiation treated uterine cervix carcinoma.
    Siracký J; Siracká E; Kovác R; Révész L
    Neoplasma; 1988; 35(3):289-96. PubMed ID: 3405337
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Comparative cytogenetic studies of a primary squamous cell carcinoma of the uterine cervix and the local recurrence of the same tumor (author's transl)].
    Dehnhard F; Breinl H; Schüssler J; Wehler V
    Geburtshilfe Frauenheilkd; 1976 Nov; 36(11):983-9. PubMed ID: 992320
    [TBL] [Abstract][Full Text] [Related]  

  • 59. DNA patterns and aggressive histopathologic features in 159 patients with cervical carcinoma.
    Strang P; Lindgren A; Frankendal B; Stendahl U
    Int J Gynecol Pathol; 1988; 7(1):56-63. PubMed ID: 3350617
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [The relationship between DNA content in cervical carcinoma cell and the clinicopathological features].
    Zhang H
    Zhonghua Bing Li Xue Za Zhi; 1989 Jun; 18(2):137-9. PubMed ID: 2582553
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.